Paper24251858
Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.
Martiniano SL and 4 others. Ann Am Thorac Soc, 2014. Cited by 100 papers, by iCite.
Cite this record
ConductScience Library. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Papers, record 24251858. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24251858
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Mycobacterium avium Complex | Major topic |
| Mycobacterium avium-intracellulare Infection | Major topic |
| Nontuberculous Mycobacteria | Major topic |
| Tuberculosis, Pulmonary | Major topic |
| Adolescent | |
| Adult | |
| Child | |
| Cohort Studies | |
| Coinfection | |
| Female | |
| Forced Expiratory Volume | |
| Humans | |
| Male | |
| Mycobacterium Infections, Nontuberculous | |
| Pseudomonas Infections | |
| Pseudomonas aeruginosa | |
| Retrospective Studies | |
| Sputum | |
| Young Adult |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 HL007670 | NHLBI NIH HHS | United States | T32HL007670 | PubMed and NIH | NIH RePORTER |
| UL1 TR001082 | NCATS NIH HHS | United States | UL1TR001082 | PubMed and NIH | NIH RePORTER |
| T32 HL007670-21 | NHLBI NIH HHS | United States | T32HL007670 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03312075 | Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients. | Background |
Source ClinicalTrials.gov
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19830845 | Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors. | Pediatr Pulmonol | 2009 | https://conductscience.org/library/papers/19830845 | PubMed |
| 2 | 20833823 | Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. | Am J Respir Crit Care Med | 2011 | https://conductscience.org/library/papers/20833823 | PubMed |
| 3 | 8131446 | Nontuberculous mycobacterial disease in adult cystic fibrosis patients. | Chest | 1993 | https://conductscience.org/library/papers/8131446 | PubMed |
| 4 | 17277290 | An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. | Am J Respir Crit Care Med | 2007 | https://conductscience.org/library/papers/17277290 | PubMed |
| 5 | 9659352 | Non-tuberculous mycobacteria in cystic fibrosis. | Thorax | 1998 | https://conductscience.org/library/papers/9659352 | PubMed |
| 6 | 12433669 | Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. | Am J Respir Crit Care Med | 2003 | https://conductscience.org/library/papers/12433669 | PubMed |
| 7 | 9872837 | Spirometric reference values from a sample of the general U.S. population. | Am J Respir Crit Care Med | 1999 | https://conductscience.org/library/papers/9872837 | PubMed |
| 8 | 21292659 | Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. | Clin Infect Dis | 2011 | https://conductscience.org/library/papers/21292659 | PubMed |
| 9 | 17145951 | Hypervirulence of a rough variant of the Mycobacterium abscessus type strain. | Infect Immun | 2007 | https://conductscience.org/library/papers/17145951 | PubMed |
| 10 | 18378709 | Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18378709 | PubMed |
| 11 | 19846643 | Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. | J Clin Microbiol | 2009 | https://conductscience.org/library/papers/19846643 | PubMed |
| 12 | 16000480 | Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. | J Clin Microbiol | 2005 | https://conductscience.org/library/papers/16000480 | PubMed |
| 13 | 12433668 | Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. | Am J Respir Crit Care Med | 2003 | https://conductscience.org/library/papers/12433668 | PubMed |
| 14 | 14720400 | Mycobacterium abscessus and children with cystic fibrosis. | Emerg Infect Dis | 2003 | https://conductscience.org/library/papers/14720400 | PubMed |
| 15 | 11303264 | Nontuberculous mycobacteria in patients with cystic fibrosis. | Clin Infect Dis | 2001 | https://conductscience.org/library/papers/11303264 | PubMed |
| 16 | 11340540 | Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic. | Clin Infect Dis | 2001 | https://conductscience.org/library/papers/11340540 | PubMed |
| 17 | 15858802 | Nontuberculous mycobacterial infection in young children with cystic fibrosis. | Pediatr Pulmonol | 2005 | https://conductscience.org/library/papers/15858802 | PubMed |
| 18 | 15684298 | Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. | Eur Respir J | 2005 | https://conductscience.org/library/papers/15684298 | PubMed |
| 19 | 17693140 | Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. | J Cyst Fibros | 2008 | https://conductscience.org/library/papers/17693140 | PubMed |
| 20 | 19467851 | Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs. | Respir Med | 2009 | https://conductscience.org/library/papers/19467851 | PubMed |
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41007135 | The Epidemiology of Nontuberculous Mycobacteria in Cystic Fibrosis. | Children (Basel) | 2025 | https://conductscience.org/library/papers/41007135 | PubMed |
| 40957819 | Evaluation of the drug interaction between rifabutin and elexacaftor/tezacaftor/ivacaftor (ETI). | J Cyst Fibros | 2026 | https://conductscience.org/library/papers/40957819 | PubMed |
| 40744839 | Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/40744839 | PubMed |
| 40171164 | Divergent host humoral innate immune response to the smooth-to-rough adaptation of Mycobacterium abscessus in chronic infection. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40171164 | PubMed |
| 40071337 | Pulmonary nontuberculous mycobacterial infections among women with cystic fibrosis and non-cystic fibrosis bronchiectasis. | Ther Adv Respir Dis | 2025 | https://conductscience.org/library/papers/40071337 | PubMed |
| 40063876 | Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis. | PLoS One | 2025 | https://conductscience.org/library/papers/40063876 | PubMed |
| 39807497 | Epidemiology, microbiology and clinical impacts of non-tuberculous mycobacteria in adult patients with cystic fibrosis. | Heliyon | 2025 | https://conductscience.org/library/papers/39807497 | PubMed |
| 39413095 | Mycobacterium avium inhibits protein kinase C and MARCKS phosphorylation in human cystic fibrosis and non-cystic fibrosis cells. | PLoS One | 2024 | https://conductscience.org/library/papers/39413095 | PubMed |
| 38978544 | Genomic epidemiology of Mycobacterium abscessus at an adult cystic fibrosis programme reveals low potential for healthcare-associated transmission. | ERJ Open Res | 2024 | https://conductscience.org/library/papers/38978544 | PubMed |
| 38117792 | Prospective healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (pHALT NTM) study: Rationale and study design. | PLoS One | 2023 | https://conductscience.org/library/papers/38117792 | PubMed |
| 38104098 | Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis. | Respir Res | 2023 | https://conductscience.org/library/papers/38104098 | PubMed |
| 37666709 | Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study. | J Cyst Fibros | 2024 | https://conductscience.org/library/papers/37666709 | PubMed |
| 37349306 | Mycobacterium abscessus VapC5 toxin potentiates evasion of antibiotic killing by ribosome overproduction and activation of multiple resistance pathways. | Nat Commun | 2023 | https://conductscience.org/library/papers/37349306 | PubMed |
| 37226498 | Recent advances in mycobacterial membrane protein large 3 inhibitor drug design for mycobacterial infections. | Expert Opin Drug Discov | 2023 | https://conductscience.org/library/papers/37226498 | PubMed |
| 36828670 | Phylogenomics of nontuberculous mycobacteria respiratory infections in people with cystic fibrosis. | Paediatr Respir Rev | 2023 | https://conductscience.org/library/papers/36828670 | PubMed |
| 36480571 | Whole blood RNA-seq demonstrates an increased host immune response in individuals with cystic fibrosis who develop nontuberculous mycobacterial pulmonary disease. | PLoS One | 2022 | https://conductscience.org/library/papers/36480571 | PubMed |
| 36417800 | Culture independent markers of nontuberculous mycobacterial (NTM) lung infection and disease in the cystic fibrosis airway. | Tuberculosis (Edinb) | 2023 | https://conductscience.org/library/papers/36417800 | PubMed |
| 36187967 | The AhR ligand phthiocol and vitamin K analogs as Pseudomonas aeruginosa quorum sensing inhibitors. | Front Microbiol | 2022 | https://conductscience.org/library/papers/36187967 | PubMed |
| 35905736 | Mycobacterium abscessus HelR interacts with RNA polymerase to confer intrinsic rifamycin resistance. | Mol Cell | 2022 | https://conductscience.org/library/papers/35905736 | PubMed |
| 35863022 | Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/35863022 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24251858
GET https://conductscience.org/api/papers/v1/24251858/references?page=2